Emergent BioSolutions Analyst Ratings
BenzingaApr 11 09:03 ET
Analysts' Top Healthcare Picks: Emergent Biosolutions (EBS), Vera Therapeutics (VERA)
TipRanksApr 11 07:20 ET
Emergent BioSolutions Analyst Ratings
BenzingaMar 7 10:37 ET
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Emergent Biosolutions (EBS)
TipRanksJan 11 10:20 ET
Emergent BioSolutions Analyst Ratings
BenzingaNov 20, 2023 08:27 ET
Emergent BioSolutions Analyst Ratings
BenzingaAug 29, 2023 06:38 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (ALNY), Galapagos (GLPG) and Emergent Biosolutions (EBS)
TipRanksMay 31, 2023 12:30 ET
What 4 Analyst Ratings Have To Say About Emergent BioSolutions
BenzingaMay 31, 2023 12:01 ET
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $22 Price Target
BenzingaMay 31, 2023 08:13 ET
Analysts Offer Insights on Healthcare Companies: Emergent Biosolutions (EBS) and HeartBeam (BEAT)
TipRanksMay 19, 2023 12:30 ET
Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $22 Price Target
BenzingaMay 19, 2023 09:33 ET
Benchmark Upgrades Emergent BioSolutions to Buy, Announces $22 Price Target
BenzingaApr 10, 2023 06:57 ET
Analysts Offer Insights on Healthcare Companies: Emergent Biosolutions (EBS), Syndax Pharmaceuticals (SNDX) and Mersana Therapeutics (MRSN)
TipRanksMar 31, 2023 08:16 ET
Emergent BioSolutions Analyst Ratings
Benzinga Analyst RatingsNov 10, 2022 13:42 ET
'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target
Benzinga Real-time NewsNov 9, 2022 13:20 ET
MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday
Benzinga Real-time NewsNov 9, 2022 08:07 ET
Emergent BioSolutions Analyst Ratings
Benzinga Analyst RatingsNov 9, 2022 07:38 ET
Chardan Capital Maintains Buy on Emergent BioSolutions, Lowers Price Target to $55
Benzinga Real-time NewsNov 9, 2022 07:38 ET
Analysts Offer Insights on Healthcare Companies: Emergent Biosolutions (EBS), Inovio Pharmaceuticals (INO) and Assembly Biosciences (ASMB)
TipRanksNov 9, 2022 06:50 ET
Chardan Cuts Price Target on Emergent Biosolutions to $55 From $65 on Slower Revenue, Profitability Growth; Keeps Buy Rating
MT NewswiresNov 9, 2022 06:35 ET
No Data
No Data